Home › Targets › MRGPRX2

MRGPRX2 (3 companies · 6 programs)

Companies with an active program directed at MRGPRX2.

Arcus Biosciences, Inc. RCUS

AB102 — Atopic Dermatitis Preclinical
AB102 — Chronic Spontaneous Urticaria Preclinical

Evommune, Inc. EVMN

EVO756 — Chronic Inducible Urticaria Phase 2
EVO756 — Migraine Phase 2

Septerna, Inc. SEPN

SEP-631 — Chronic Inducible Urticaria
SEP-631 — Chronic Spontaneous Urticaria Phase 1